Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Miami
Dana-Farber Cancer Institute
Mayo Clinic
UNC Lineberger Comprehensive Cancer Center
Tongji Hospital
M.D. Anderson Cancer Center
Washington University School of Medicine
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
West China Hospital
M.D. Anderson Cancer Center
EtiraRx Australia Pty Ltd
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Washington University School of Medicine
Brown University
Institut Paoli-Calmettes
Mayo Clinic
QuantumLeap Healthcare Collaborative
Sunnybrook Health Sciences Centre
Ohio State University Comprehensive Cancer Center
Rutgers, The State University of New Jersey
Centre Leon Berard
HonorHealth Research Institute
Stanford University
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Abramson Cancer Center at Penn Medicine
University of California, San Diego
Dana-Farber Cancer Institute
Masonic Cancer Center, University of Minnesota
H. Lee Moffitt Cancer Center and Research Institute
University of Miami
Alliance for Clinical Trials in Oncology
University of Southern California
Chinese PLA General Hospital
Case Comprehensive Cancer Center
University of Alabama at Birmingham
Yale University
University of Chicago
University of Chicago
UNC Lineberger Comprehensive Cancer Center
Case Comprehensive Cancer Center
Radboud University Medical Center
Chang Gung Memorial Hospital
Case Comprehensive Cancer Center
NYU Langone Health